The Promise

Premium

Part of the promise of personalized medicine is that patients will get treatments tailored to their specific genomic profile and situation. That is, of course, dependent upon physicians knowing to order such tests and being able to interpret the results in light of their patients' particular cases. And it's not clear that they do. A number of studies, including a 2011 Genetics in Medicine study from Baylor College of Medicine researchers, have reported that many physicians do not properly interpret genetic tests and their implications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.